CBD
NHS guidelines on prescription cannabis to be challenged in court
August 18, 2020Manufacturing and Production, Research and Development CBD, cannabis, epilepsy
The cannabis guidelines followed by the NHS are set to be challenged in court by the parents of a three-year-old …
FDA approves CBD treatment for seizures associated with tuberous sclerosis complex
August 3, 2020Sales and Marketing CBD, tsc
The FDA has approved Epidiolex (cannabidiol) as a treatment for seizures associated with tuberous sclerosis complex (TSC) in patients over …
FDA sets out guidelines on cannabis derived drugs
July 22, 2020Research and Development CBD, CBD Oil
The FDA has released their guidelines on the rules companies should follow when developing cannabis derived drugs. The guidelines cover …
UK Home office reclassifies Epidyolex as a Schedule 5 drug
June 24, 2020Research and Development CBD, cannabiodiol, cannabis
The Home Office has announced that the drug Epidyolex (cannabidiol) has been reclassified as a Schedule 5 drug, a move …
NHS to fast track cannabis-based treatment for epilepsy
December 23, 2019Sales and Marketing CBD, CBD Oil, cannabis, drug treatment, epilepsy, thc
The NHS has fast-tracked the drug Epidyolex, a cannabidiol (CBD), to be available for epilepsy treatment through the NHS in …
British Pharmacists call for regulation on non-medicinal CBD products
December 17, 2019Manufacturing and Production CBD, CBD Oil, CBD Products, cannabis
Pharmacists are calling for more checks on products containing Cannabis derivative cannabidiol (CBD) that are sold in shops across the …
FDA issues warning to CBD company Curaleaf
July 29, 2019Sales and Marketing CBD, FDA, cannabidiol, curaleaf, pharma, regulation
The FDA has issued a warning to Massachusetts-based CBD company Curaleaf over the firm’s use of unsubstantiated claims about the …
Synthetic, non-intoxicating CBD analogue treats seizures in rats
May 31, 2019Medical Communications CBD, H2CBD, cannabidiol, medicinal cannabis, pharma
A synthetic, non-intoxicating cannabidiol (CBD)-analogue is effective at treating seizures in rats, according to researchers at the University of California, …
GW Pharma’s Epidiolex scores in rare childhood onset epilepsy Phase 3 trial
May 7, 2019Manufacturing and Production, Sales and Marketing CBD, Epidiolex, GW Pharma, cannabidiol, cannabis, epilepsy, tsc
GW Pharma’s Epidiolex has shown positive Phase 3 trial results for the fifth time in a row, after meeting primary …
CBD could be used to deliver drugs into the brain, research shows
April 18, 2019Research and Development BBB, CBD, CNS, brain, drug delivery, neuroscience
Cannabidiol (CBD), one of 113 cannabinoids in cannabis plants, could be used to deliver medicines into the brain, according to …
CBD dampens activity in brain regions associated with psychosis, study shows
August 30, 2018Research and Development CBD, King's College London, Kings College London, Marijuana, psychosis, study
Cannabidiol (CBD), one of the major constituents of cannabis, may be beneficial for patients with psychotic disorders due to its …
